Flu season ends with a whisper, not a bang.

Published Date: 14 Mar 2023

The 2022-2023 flu season is on the edge of life which has been predicted for half of January and most of February.

Read Full News

Latest News

CSF Biomarker Panel May Improve Diagnosis of CNS Lymphoma

A prospective multicenter study validates three cerebrospinal fluid biomarkers that may aid diagnosis of suspected primary CNS lymphoma.

Health Data Platform Connects Hospitals Across Provinces

The VITAL system collects near real-time hospital data with the aim of optimizing healthcare delivery, research, and innovation while protecting privacy.

Blood Test Flags Gynaecologic Cancer Risk in NHS Trial

A blood test correctly flags 99% of gynaecologic cancers as high risk in the largest NHS AI triage trial yet.

Focal Therapy Shows Favorable Long-Term Outcomes

A large registry study finds low 10-year prostate cancer mortality after focal HIFU or cryotherapy, but experts caution randomized comparisons with standard treatments are needed.

Parental Anxiety Persists Up to 2 Years After NICU Discharge

Parents of extremely premature infants show higher anxiety levels well beyond hospital discharge.

Holmium Enucleation Safe for Recurrent Prostatic Obstruction

Holmium laser enucleation of the prostate appears safe and effective for patients who have recurrent benign prostatic obstruction.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Latest News

A prospective multicenter study validates three cerebrospinal fluid biomarkers that may aid diagnosis of suspected primary CNS lymphoma.

The VITAL system collects near real-time hospital data with the aim of optimizing healthcare delivery, research, and innovation while protecting privacy.

A blood test correctly flags 99% of gynaecologic cancers as high risk in the largest NHS AI triage trial yet.

A large registry study finds low 10-year prostate cancer mortality after focal HIFU or cryotherapy, but experts caution randomized comparisons with standard treatments are needed.

Parents of extremely premature infants show higher anxiety levels well beyond hospital discharge.

Holmium laser enucleation of the prostate appears safe and effective for patients who have recurrent benign prostatic obstruction.

News All Time

Freezing of Gait in Parkinson’s: What’s Beyond Medication?

A conference review highlights how combining cognitive, motor, and sensory training with cueing strategies may improve freezing of gait in Parkinson’s disease.

What Doctors Should Know About Autism ‘Unmasking’ in Girls

More teen girls and young women are self-identifying as autistic, giving clinicians a unique opportunity to help patients that goes beyond confirming or ruling out a diagnosis.

What the Fourth Year of Med School Is Really Like

Fourth-year med students are in for a lot of stress, anxiety, and expense, just not from studying.

Home Eye Scans Best Suited for High-Cost Retina Meds

Home-based optical tomography may only be cost-effective for patients on more expensive treatments.

Low-FODMAP Diet May Ease Symptoms of Postprandial Dyspepsia

A diet low in fermentable carbohydrates offers better symptom relief and quality of life than traditional dietary advice in adults with postprandial distress syndrome.

Why Paris Faces Europe’s Highest Heat Death Risk

New research suggests extreme heat can worsen neurologic disease, pregnancy outcomes, and mortality, with risk driven as much by poverty and housing as by temperature.

Why France Is Leading on Tick-Borne Diseases

France has built a national tick-borne disease network, expanded PTLDS guidance, and launched new cohorts to track Lyme disease from bite to long-term outcomes.

Hepatitis B Vaccination Crucial for Guinea-Bissau: Ethicist

Ethicist Art Caplan discusses hepatitis B vaccination and ethical considerations for a suspended clinical trial in Guinea-Bissau.

Population-Wide CRC Screening May Cut Health Inequities

After launching an organized CRC screening program in Hong Kong, socioeconomic disparities have narrowed but persist among certain groups.

Medical Cannabis: What to Tell Your Patients

Evidence supports cannabis-based therapies for a limited number of conditions. Here’'s what clinicians should know — and tell patients — about the potential benefits, risks, and remaining uncertainties.

Poor Access to MASLD Care for Most US Patients

Most US counties lack access to elastography imaging, gastroenterologists, or both, creating major geographic gaps in care for MASLD.

Tavapadon Improves Early PD Symptoms: Full Phase 3 Results

The selective D1/D5 agonist significantly improved Parkinson’s disease motor symptoms, with low rates of somnolence and impulse control disorders, full results of the phase 3 TEMPO-2 study show.

Work Stress Predicts Depression Among Ambulance Staff

An explanatory study identifies organisational stressors, a lack of mental rest, and stress appraisals as vital predictors of depression among ambulance staff.

TIPS in Liver Failure With Fluid Overload Reduces Death Risk

Transjugular intrahepatic portosystemic shunt insertion is associated with a lower risk for short-term mortality in patients with acute-on-chronic liver failure with fluid overload.

England to Screen Newborns for Spinal Muscular Atrophy

The rollout follows Scotland’s lead and was fast-tracked after a parliamentary debate and a 150,000-signature petition.

The Alarming Rise of Early-Onset Lung and GI Cancers

At ASCO 2026, Drs Olazagasti and Bernabe discuss the rise of early-onset cancers and how to close critical screening gaps.

Recommended News For You

Charles III, King of Kings, is Cancerous.

Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows

Chemicals in Sewage Sludge Fertilizer Pose Cancer Risk, EPA Says

recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients

Radiation therapy can promote amphiregulin, which increases growth of metastases

Recommended Articles For You

Seeing the Unseen: Examining Chancroid Through Images 

Multiple Myeloma: Understanding the Basics  

Unlocking the Potential of Palbociclib: A Comprehensive Overview 

The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975

2.

Researchers Challenge USPSTF's Lung Cancer Screening Criteria

3.

Prostate cancer Q&A: Improving detection and reducing overtreatment

4.

Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

5.

How 7,000 steps a day could help reduce your risk of cancer

1.

MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed

2.

Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights

3.

How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement?

4.

Comprehensive Applications in Oncology and Quality Improvement

5.

Apheresis vs. IVMP in Cancer Treatment: A Tale of Two Titans

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

3.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

5.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot